
Sharekhan has issued a research report claiming that the the acquisition of Natrol is a positive development for Aurobindo Pharma and that the stock should be bought
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Recent Comments